{
    "code": "52026921",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026921",
    "time": "2020-03-06 04:54:11",
    "許可證字號": "衛部藥輸字第026921號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "110\/08\/08",
    "發證日期": "105\/08\/08",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202692107",
    "中文品名": "沛美曲賽凍晶注射劑",
    "英文品名": "DBL Pemetrexed (as Disodium) powder for injection",
    "適應症": "1.併用Cisplatin是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第一線化療用藥。2.單一藥物是局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第二線治療用藥。4.與Cisplatin併用於治療惡性肋膜間質細胞瘤。",
    "劑型": "243凍晶注射劑",
    "包裝": "100毫克，500毫克玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "PEMETREXED DISODIUM HEPTAHYDRATE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "新北市淡水區中正東路二段１７７號",
    "主製造廠": [
        {
            "製造廠名稱": "FIN0567000  ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED",
            "製造廠廠址": "PHARMEZ SPECIAL ECONOMIC ZONE, PLOT NO.3, SARKHEJ-BAVLA ROAD, N.H. NO. 8A, VILLAGE: MATODA, TALUKA: SANAND, DISTRICT-AHMEDABAD-382 213 (GUJARAT), INDIA",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1004002410",
            "成分名稱": "PEMETREXED DISODIUM HEPTAHYDRATE",
            "含量描述": "Pemetrexed Disodium Hemipentahydrate (equivalent to Pemetrexed.....100mg)",
            "含量": "110.2800000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1004002410",
            "成分名稱": "PEMETREXED DISODIUM HEPTAHYDRATE",
            "含量描述": "Pemetrexed Disodium Hemipentahydrate (equivalent to Pemetrexed.....500mg)",
            "含量": "551.4000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "HSP Pemetrexed (as disodium) Powder for injection LLD MoH 20190823-1 for approval-109-01-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026921&Seq=002&Type=9"
        },
        {
            "title": "DBL Pemetrexed100mg vial label-105-12-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026921&Seq=005&Type=8"
        }
    ]
}